Suppr超能文献

利用基因靶向技术研究哺乳动物细胞DNA修复突变体中的重组。

Use of gene targeting to study recombination in mammalian cell DNA repair mutants.

作者信息

Nairn Rodney S, Adair Gerald M

机构信息

Department of Carcinogenesis, Science Park-Research Division, University of Texas M.D. Anderson Cancer Center, Smithville, TX, USA.

出版信息

Methods Mol Biol. 2006;314:133-54. doi: 10.1385/1-59259-973-7:133.

Abstract

Gene targeting by homologous recombination in mammalian cells is an important tool for generating genetically modified mice used for modeling human diseases. Gene targeting approaches are also useful for studying the mechanisms of homologous recombination. We have developed gene targeting methods that we have specifically used to investigate the mechanisms of recombination in cultured mammalian cells. In this chapter, we describe the generation of Chinese hamster ovary (CHO) cell gene disruption ("knockout") mutants in the repair/recombination gene ERCC1. Using this approach, we have constructed pairs of isogenic ERCC1-proficient and -deficient (null) CHO cell lines and used them as recipients for gene targeting assays in which a hemizygous mutant hamster adenine phosphoribosyltransferase (APRT) locus is corrected by homologous recombination with plasmid vectors containing hamster APRT DNA sequence homologous to the target gene in each cell line. The configuration of the targeting vector leads to experimental outcomes in which certain classes of APRTrecombinants are over- or under-represented depending on the repair gene status of the transfection recipient. We describe methods both for targeted gene knockout of ERCC1, and for APRT targeted gene correction by homologous recombination, and some of our experimental results using these approaches.

摘要

在哺乳动物细胞中,通过同源重组进行基因打靶是生成用于人类疾病建模的基因工程小鼠的重要工具。基因打靶方法对于研究同源重组机制也很有用。我们已经开发了基因打靶方法,专门用于研究培养的哺乳动物细胞中的重组机制。在本章中,我们描述了在修复/重组基因ERCC1中生成中国仓鼠卵巢(CHO)细胞基因破坏(“敲除”)突变体的过程。使用这种方法,我们构建了同基因的ERCC1功能正常和缺陷(缺失)的CHO细胞系对,并将它们用作基因打靶测定的受体,其中半合子突变仓鼠腺嘌呤磷酸核糖转移酶(APRT)基因座通过与含有与每个细胞系中靶基因同源的仓鼠APRT DNA序列的质粒载体进行同源重组来校正。打靶载体的构型导致实验结果,即某些类型的APR重组体根据转染受体的修复基因状态而过度或不足表达。我们描述了ERCC1靶向基因敲除以及通过同源重组进行APRT靶向基因校正的方法,以及使用这些方法得到的一些实验结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验